A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia

Molecular and Cellular Proteomics

Volumn 9, Issue 5, 2010, Pages 780-790

  Zhang, Yi ^a   Askenazi, Manor ^a,b,c   Jiang, Jingrui ^a   Luckey, C John ^b   Griffin, James D ^a   Marto, Jarrod A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; JANUS KINASE 2; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT5A PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL; HUMAN; HUMAN CELL; ION TRAP MASS SPECTROMETRY; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE, TUMOR; DOWN-REGULATION; FMS-LIKE TYROSINE KINASE 3; ISOTOPE LABELING; JANUS KINASES; LEUKEMIA, MYELOID, ACUTE; LIGANDS; MICE; MODELS, BIOLOGICAL; MUTANT PROTEINS; MUTATION; PEPTIDES; PHOSPHOTYROSINE; PROTEIN STRUCTURE, TERTIARY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 77951820417     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900452-MCP200     Document Type: Article

References (59)

1. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling. Nature 411, 355-365
2. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225
3. Gilliland, D. G., and Griffin, J. D. (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood 100, 1532-1542
4. Small, D. (2006) FLT3 mutations: biology and treatment. Hematology Am. Soc. Hematol. Educ. Program 1, 178-184
5. Knapper, S. (2007) FLT3 inhibition in acute myeloid leukaemia. Br. J. Haematol. 138, 687-699 (Pubitemid 47313203)
6. Choudhary, C., Schwäble, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T., Berdel, W. E., Müller-Tidow, C., and Serve, H. (2005) AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations. Blood 106, 265-273 (Pubitemid 40967202)
7. Grundler, R., Miething, C., Thiede, C., Peschel, C., and Duyster, J. (2005) FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model. Blood 105, 4792-4799 (Pubitemid 40807305)
8. Rocnik, J. L., Okabe, R., Yu, J. C., Lee, B. H., Giese, N., Schenkein, D. P., and Gilliland, D. G. (2006) Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD. Blood 108, 1339-1345 (Pubitemid 44232034)
9. Domon, B., and Aebersold, R. (2006) Mass spectrometry and protein analysis. Science 312, 212-217
10. Mann, M., Hendrickson, R. C., and Pandey, A. (2001) Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 70, 437-473 (Pubitemid 32662217)
11. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
12. Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., Johnstone, R., Mohammed, A. K., and Hamon, C. (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895-1904 (Pubitemid 36438013)
13. Shadforth, I. P., Dunkley, T. P., Lilley, K. S., and Bessant, C. (2005) i-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 6, 145-145
14. Lin, W. T., Hung, W. N., Yian, Y. H., Wu, K. P., Han, C. L., Chen, Y. R., Chen, Y. J., Sung, T. Y., and Hsu, W. L. (2006) Multi-Q: a fully automated tool for multiplexed protein quantitation. J. Proteome Res. 5, 2328-2338
15. Boehm, A. M., Pütz, S., Altenhöfer, D., Sickmann, A., and Falk, M. (2007) Precise protein quantification based on peptide quantification using iTRAQ. BMC Bioinformatics 8, 214-214 (Pubitemid 47225253)
16. Oberg, A. L., Mahoney, D. W., Eckel-Passow, J. E., Malone, C. J., Wolfinger, R. D., Hill, E. G., Cooper, L. T., Onuma, O. K., Spiro, C., Therneau, T. M., and Bergen, H. R., 3rd (2008) Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J. Proteome Res. 7, 225-233
17. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., Reader, V., Sweetman, G., Bauer, A., Bouwmeester, T., Hopf, C., Kruse, U., Neubauer, G., Ramsden, N., Rick, J., Kuster, B., and Drewes, G. (2007) Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044 (Pubitemid 47517638)
18. DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2005) Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 4, 377-386 (Pubitemid 40548142)
19. Garbis, S. D., Tyritzis, S. I., Roumeliotis, T., Zerefos, P., Giannopoulou, E. G., Vlahou, A., Kossida, S., Diaz, J., Vourekas, S., Tamvakopoulos, C., Pavlakis, K., Sanoudou, D., and Constantinides, C. A. (2008) Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 7, 3146-3158
20. Hundertmark, C., Fischer, R., Reinl, T., May, S., Klawonn, F., and Jänsch, L. (2009) MS-specific noise model reveals the potential of iTRAQ in quantitative proteomics. Bioinformatics 25, 1004-1011
21. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
22. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999 (Pubitemid 29474856)
23. Ficarro, S. B., Zhang, Y., Lu, Y., Moghimi, A. R., Askenazi, M., Hyatt, E., Smith, E. D., Boyer, L., Schlaeger, T. M., Luckey, C. J., and Marto, J. A. (2009) Improved electrospray ionization efficiency compensates for diminished chromatographic resolution and enables proteomics analysis of tyrosine signaling in embryonic stem cells. Anal. Chem. 81, 3440-3447
24. Zhang, Y., Ficarro, S. B., Li, S., and Marto, J. A. (2009) Optimized Orbitrap HCD for quantitative analysis of phosphopeptides. J. Am. Soc. Mass Spectrom. 20, 1425-1434
25. Parikh, J. R., Askenazi, M., Ficarro, S. B., Cashorali, T., Webber, J. T., Blank, N. C., Zhang, Y., and Marto, J. A. (2009) multiplierz: an extensible API based desktop environment for proteomics data analysis. BMC Bioinformatics 10, 364
26. Sadler, W. A., and Smith, M. H. (1986) A reliable method for estimating the variance function in immunoassay. Comput. Stat. Data Anal. 3, 227-239
27. Davidian, M., and Carroll, R. J. (1987) Variance function estimation. J. Am. Stat. Assoc. 82, 1079-1091
28. Storey, J. D., and Tibshirani, R. (2003) Statistical significance for genome-wide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445
29. Olsen, J. V., Macek, B., Lange, O., Makarov, A., Horning, S., and Mann, M. (2007) Higher-energy C-trap dissociation for peptide modification analysis. Nat. Methods 4, 709-712 (Pubitemid 47338163)
30. Askenazi, M., Parikh, J. R., and Marto, J. A. (2009) mzAPI: a new strategy for efficiently sharing mass spectrometry data. Nat. Methods 6, 240-241
31. Yang, Y. H., Dudoit, S., Luu, P., and Speed, T. P. (2001) Normalization for cDNA microarray data, in Microarrays: Optical Technologies and Informatics (Bittner, M. L., Chen, Y., Dorsel, A. N., and Dougherty, E. R., eds) pp. 141-152, SPIE, San Jose, CA
32. Posener, D. W. (1974) Precision in measuring resonance spectra. J. Magn. Reson. 14, 121-128
33. Chen, L., Cottrell, C. E., and Marshall, A. G. (1986) Effect of signal-to-noise ratio and number of data points upon precision in measurement of peak amplitude, position and width in Fourier transform spectrometry. Chemom. Intell. Lab. Syst. 1, 51-58
34. Liang, Z. M., and Marshall, A. G. (1990) Precise relative ion abundances from Fourier transform ion cyclotron resonance magnitude-mode mass spectra. Anal. Chem. 62, 70-75 (Pubitemid 20065872)
35. Liang, Z., and Marshall, A. G. (1990) Time-domain (interferogram) and frequency-domain (absorption-mode and magnitude-mode) noise and precision in Fourier transform spectrometry. Appl. Spectrosc. 44, 766-775 (Pubitemid 20707412)
36. Bantscheff, M., Boesche, M., Eberhard, D., Matthieson, T., Sweetman, G., and Kuster, B. (2008) Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer. Mol. Cell. Proteomics 7, 1702-1713
37. Makarov, A., Denisov, E., Lange, O., and Horning, S. (2006) Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. J. Am. Soc. Mass Spectrom. 17, 977-982 (Pubitemid 43928612)
38. Venable, J. D., Wohlschlegel, J., McClatchy, D. B., Park, S. K., and Yates, J. R., 3rd. (2007) Relative quantification of stable isotope labeled peptides using a linear ion trap-Orbitrap hybrid mass spectrometer. Anal. Chem. 79, 3056-3064 (Pubitemid 46640527)
39. Ow, S. Y., Salim, M., Noirel, J., Evans, C., Rehman, I., and Wright, P. C. (2009) iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". J. Proteome Res. 8, 5347-5355
40. Choudhary, C., Müller-Tidow, C., Berdel, W. E., and Serve, H. (2005) Signal transduction of oncogenic Flt3. Int. J. Hematol. 82, 93-99
41. Zheng, R., and Small, D. (2005) Mutant FLT3 signaling contributes to a block in myeloid differentiation. Leuk. Lymphoma 46, 1679-1687 (Pubitemid 43203100)
42. Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., and Griffin, J. D. (2002) Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412. Cancer Cell 1, 433-443 (Pubitemid 41039124)
43. Skaggs, B. J., Gorre, M. E., Ryvkin, A., Burgess, M. R., Xie, Y., Han, Y., Komisopoulou, E., Brown, L. M., Loo, J. A., Landaw, E. M., Sawyers, C. L., and Graeber, T. G. (2006) Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants. Proc. Natl. Acad. Sci. U.S.A. 103, 19466-19471 (Pubitemid 46026054)
44. Feng, J., Witthuhn, B. A., Matsuda, T., Kohlhuber, F., Kerr, I. M., and Ihle, J. N. (1997) Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17, 2497-2501 (Pubitemid 27175130)
45. Tonks, N. K., and Neel, B. G. (1996) From form to function: signaling by protein tyrosine phosphatases. Cell 87, 365-368 (Pubitemid 26374311)
46. Jiao, H., Berrada, K., Yang, W., Tabrizi, M., Platanias, L. C., and Yi, T. (1996) Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16, 6985-6992 (Pubitemid 26389758)
47. Klingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G., and Lodish, H. F. (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729-738
48. Minoo, P., Zadeh, M. M., Rottapel, R., Lebrun, J. J., and Ali, S. (2004) A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103, 1398-1407 (Pubitemid 38168655)
49. Du, P., Stolovitzky, G., Horvatovich, P., Bischoff, R., Lim, J., and Suits, F. (2008) A noise model for mass spectrometry based proteomics. Bioinformatics 24, 1070-1077 (Pubitemid 351514057)
50. Anderle, M., Roy, S., Lin, H., Becker, C., and Joho, K. (2004) Quantifying reproducibility for differential proteomics: noise analysis for protein liquid chromatography-mass spectrometry of human serum. Bioinformatics 20, 3575-3582 (Pubitemid 40136793)
51. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
52. Wang, G., Wu, W. W., Zeng, W., Chou, C. L., and Shen, R. F. (2006) Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J. Proteome Res. 5, 1214-1223 (Pubitemid 43727800)
53. Roy, S. M., and Becker, C. H. (2007) Quantification of proteins and metabolites by mass spectrometry without isotopic labeling. Methods Mol. Biol. 359, 87-105 (Pubitemid 350183223)
54. Weisberg, E., Manley, P. W., Cowan-Jacob, S. W., Hochhaus, A., and Griffin, J. D. (2007) Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat. Rev. Cancer 7, 345-356 (Pubitemid 46652483)
55. Ostman, A., and Böhmer, F. D. (2001) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 11, 258-266 (Pubitemid 32441736)
56. Zhang, J., Somani, A. K., and Siminovitch, K. A. (2000) Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12, 361-378
57. Wu, C., Sun, M., Liu, L., and Zhou, G. W. (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306, 1-12 (Pubitemid 36351390)
58. Chen, P., Levis, M., Brown, P., Kim, K. T., Allebach, J., and Small, D. (2005) FLT3/ITD mutation signaling includes suppression of SHP-1. J. Biol. Chem. 280, 5361-5369 (Pubitemid 40280010)
59. Choudhary, C., Brandts, C., Schwable, J., Tickenbrock, L., Sargin, B., Ueker, A., Böhmer, F. D., Berdel, W. E., Müller-Tidow, C., and Serve, H. (2007) Activation mechanisms of STAT5 by oncogenic Flt3-ITD. Blood 110, 370-374 (Pubitemid 47026856)